• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by SeaSpine Holdings Corporation (Amendment)

    2/14/22 11:45:59 AM ET
    $SPNE
    Medical Specialities
    Health Care
    Get the next $SPNE alert in real time by email
    SC 13G/A 1 d317244dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 7)*

     

     

    SEASPINE HOLDINGS CORPORATION

    (Name of Issuer)

    Common Stock, $0.01 par value per share

    (Title of Class of Securities)

    81255T 108

    (CUSIP Number)

    December 31, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ☐

    Rule 13d-1(b)

     

      ☒

    Rule 13d-1(c)

     

      ☐

    Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 81255T 108    SCHEDULE 13G    Page 2 of 10

     

      1    

      Names of reporting persons

     

      Tru St Partnership LP

      2  

      Check the appropriate box if a member of a group

     

      (a)  ☒        (b)  ☐

     

      3  

      SEC use only

     

      4  

      Citizenship or place of organization

     

      Pennsylvania

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with

       5    

      Sole voting power

     

      0

       6  

      Shared voting power

     

      1,997,068

       7  

      Sole dispositive power

     

      0

       8  

      Shared dispositive power

     

      1,997,068

      9    

      Aggregate amount beneficially owned by each reporting person

     

      1,997,068

    10  

      Check if the aggregate amount in Row (9) excludes certain shares

     

      Not Applicable

    11  

      Percent of class represented by amount in Row 9

     

      5.48%

    12  

      Type of reporting person

     

      PN


    CUSIP No. 81255T 108    SCHEDULE 13G    Page 3 of 10

     

      1    

      Names of reporting persons

     

      Provco Leasing Corporation

      2  

      Check the appropriate box if a member of a group

     

      (a)  ☒        (b)  ☐

     

      3  

      SEC use only

     

      4  

      Citizenship or place of organization

     

      Delaware

    Number of

    shares

     beneficially 

    owned by

    each

    reporting

    person

    with

       5    

      Sole voting power

     

      7,779

       6  

      Shared voting power

     

      1,997,068

       7  

      Sole dispositive power

     

      7,779

       8  

      Shared dispositive power

     

      1,997,068

      9    

      Aggregate amount beneficially owned by each reporting person

     

      2,004,847

    10  

      Check if the aggregate amount in Row (9) excludes certain shares

     

      Not Applicable

    11  

      Percent of class represented by amount in Row 9

     

      5.50%

    12  

      Type of reporting person

     

      CO


    CUSIP No. 81255T 108    SCHEDULE 13G    Page 4 of 10

     

    ITEM 1.    (a)   

    Name of Issuer:

     

    SeaSpine Holdings Corporation (the “Issuer”)

     

       (b)   

    Address of Issuer’s Principal Executive Offices:

     

    5770 Armada Drive, Carlsbad, CA 92008

     

    ITEM 2.    (a)   

    Name of Person Filing:

     

    See (c) below

     

       (b)   

    Address or Principal Business Office:

     

    See (c) below

     

       (c)   

    Citizenship of each Reporting Person is:

     

    Tru St Partnership LP

    795 East Lancaster Avenue, Suite 200

    Villanova, Pennsylvania 19085

    Pennsylvania limited partnership

     

    Provco Leasing Corporation

    1105 N. Market Street, Suite 602

    Wilmington, Delaware 19810

    Delaware corporation

     

       (d)   

    Title of Class of Securities:

     

    Common Stock, $0.01 par value per share (“Common Stock”)

     

       (e)   

    CUSIP Number: 81255T 108

     

    ITEM 3.       Not applicable.


    CUSIP No. 81255T 108    SCHEDULE 13G    Page 5 of 10

     

    ITEM 4.      

    Ownership

     

       (a)   

    Amount beneficially owned: As of December 31, 2021, Tru St Partnership LP (“Tru St”) may be deemed the beneficial owner of 1,997,068 shares of common stock. Provco Leasing is the corporate general partner of Tru St. Provco Leasing is also the beneficial owner of 7,779 shares of common stock.

     

       (b)   

    Percent of class: Based on 36,441,778 shares of the Issuer’s common stock outstanding as publicly reported on November 1, 2021 on the Issuer’s Form 10-Q for the third quarter ended September 30, 2021, Tru St, may be deemed the beneficial owner of 5.48% of the Issuer’s common stock; Provco Leasing may be deemed the beneficial owner of 5.50% of the Issuer’s common stock.

     

       (c)   

    The Reporting Persons have the power to vote or dispose of the number of shares as follows:

     

         

    (i) Sole power to vote or direct the vote. Tru St may be deemed to have sole power to vote or direct the vote of 0 shares of common stock. Provco Leasing may be deemed to have sole power to vote or direct the vote of 7,779 shares of common stock.

     

         

    (ii) Shared power to vote or direct the vote. As of December 31, 2021, Tru St and Provco Leasing may be deemed to share the power to vote or direct the vote with respect to 1,997,068 shares of common stock.

     

         

    (iii) Sole power to dispose or direct the disposition. Tru St has sole power to dispose or control the disposition of 0 shares of common stock. Provco Leasing has the sole power to dispose or control the disposition of 7,779 shares of common stock.

     

          (iv) Shared power to dispose or direct the disposition. As of December 31, 2021, Tru St, and Provco Leasing may be deemed to have shared power to dispose of or shared power to direct the disposition of 1,997,068 shares of common stock.


    CUSIP No. 81255T 108    SCHEDULE 13G    Page 6 of 10

     

    ITEM 5.       Ownership of Five Percent or Less of a Class
          Not applicable.
    ITEM 6.       Ownership of More than Five Percent on Behalf of Another Person
          Not applicable.
    ITEM 7.       Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
          Not applicable.
    ITEM 8.       Identification and Classification of Members of the Group
          See Exhibit 99.1 below.
    ITEM 9.       Notice of Dissolution of Group
          Not applicable.
    ITEM 10.       Certification
          By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


    CUSIP No. 81255T 108    SCHEDULE 13G    Page 7 of 10

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: February 14, 2022

     

    TRU ST PARTNERSHIP LP
    By:  

    /s/ Gary DiLella

    Name:   Gary DiLella
    Its:        Vice President
    PROVCO LEASING CORPORATION
    By:  

    /s/ Gary DiLella

    Name:   Gary DiLella
    Its:        Vice President


    CUSIP No. 81255T 108    SCHEDULE 13G    Page 8 of 10

     

    LIST OF EXHIBITS

     

    Exhibit No.

      

    Description

    99.1    Group Members
    99.2    Joint Filing Agreement
    Get the next $SPNE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SPNE

    DatePrice TargetRatingAnalyst
    11/2/2022$12.00 → $6.75Buy → Hold
    Truist
    4/22/2022$27.00 → $21.00Overweight
    Cantor Fitzgerald
    4/13/2022$20.00Buy
    Truist
    12/21/2021$25.00 → $20.00Buy
    Truist Securities
    10/28/2021$100.00Buy
    Loop Capital
    More analyst ratings

    $SPNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by SeaSpine Holdings Corporation (Amendment)

      SC 13G/A - SeaSpine Holdings Corp (0001637761) (Subject)

      1/31/23 1:58:01 PM ET
      $SPNE
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by SeaSpine Holdings Corporation (Amendment)

      SC 13G/A - SeaSpine Holdings Corp (0001637761) (Subject)

      2/14/22 11:45:59 AM ET
      $SPNE
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by SeaSpine Holdings Corporation (Amendment)

      SC 13G/A - SeaSpine Holdings Corp (0001637761) (Subject)

      2/3/22 4:41:28 PM ET
      $SPNE
      Medical Specialities
      Health Care

    $SPNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SeaSpine downgraded by Truist with a new price target

      Truist downgraded SeaSpine from Buy to Hold and set a new price target of $6.75 from $12.00 previously

      11/2/22 6:34:40 AM ET
      $SPNE
      Medical Specialities
      Health Care
    • Cantor Fitzgerald resumed coverage on SeaSpine with a new price target

      Cantor Fitzgerald resumed coverage of SeaSpine with a rating of Overweight and set a new price target of $21.00 from $27.00 previously

      4/22/22 9:10:58 AM ET
      $SPNE
      Medical Specialities
      Health Care
    • Truist resumed coverage on SeaSpine with a new price target

      Truist resumed coverage of SeaSpine with a rating of Buy and set a new price target of $20.00

      4/13/22 7:17:39 AM ET
      $SPNE
      Medical Specialities
      Health Care

    $SPNE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SeaSpine Announces 100th Placement of 7D FLASH™ Navigation System

      CARLSBAD, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the placement of its 100th 7D FLASH™ Navigation System globally. The 7D FLASH™ Navigation System uses visible light to create a three-dimensional image for surgical navigation in just seconds, which is expected to result in shorter and more efficient spinal procedures with less radiation exposure. It is the only marketed image-guidance system that utilizes novel and proprietary camera-based technology, coupled with machine-vision algorithms, to eliminate the long-standing fru

      12/27/22 4:05:00 PM ET
      $SPNE
      Medical Specialities
      Health Care
    • Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing

      Orthofix (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that John Bostjancic will serve as Chief Financial Officer (CFO) for the new combined company, effective upon the completion of their pending merger. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221118005106/en/ Bostjancic currently serves as the CFO and Chief Operating Officer of SeaSpine, roles he has held since 2015 and 2022 respectively. Previously, Bostjancic served as Treasurer and Sen

      11/18/22 7:00:00 AM ET
      $OFIX
      $SPNE
      Medical/Dental Instruments
      Health Care
      Medical Specialities
    • Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing

      LEWISVILLE, Texas and CARLSBAD, Calif., Nov. 18, 2022 (GLOBE NEWSWIRE) -- Orthofix (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpine (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that John Bostjancic will serve as Chief Financial Officer (CFO) for the new combined company, effective upon the completion of their pending merger. Bostjancic currently serves as the CFO and Chief Operating Officer of SeaSpine, roles he has held since 2015 and 2022 respectively. Previously, Bostjancic served as Treasurer and Senior Vice President from 2015 through 2022, and as

      11/18/22 7:00:00 AM ET
      $OFIX
      $SPNE
      Medical/Dental Instruments
      Health Care
      Medical Specialities

    $SPNE
    SEC Filings

    See more
    • SEC Form CT ORDER filed by SeaSpine Holdings Corporation

      CT ORDER - SeaSpine Holdings Corp (0001637761) (Filer)

      4/3/23 8:19:25 AM ET
      $SPNE
      Medical Specialities
      Health Care
    • SEC Form 15-12G filed by SeaSpine Holdings Corporation

      15-12G - SeaSpine Holdings Corp (0001637761) (Filer)

      1/17/23 4:31:53 PM ET
      $SPNE
      Medical Specialities
      Health Care
    • SEC Form EFFECT filed by SeaSpine Holdings Corporation

      EFFECT - SeaSpine Holdings Corp (0001637761) (Filer)

      1/12/23 12:15:22 AM ET
      $SPNE
      Medical Specialities
      Health Care

    $SPNE
    Leadership Updates

    Live Leadership Updates

    See more
    • SeaSpine® Announces New Senior Leadership Team Appointments

      CARLSBAD, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that John Bostjancic, previously the Company's Senior Vice President, Chief Financial Officer, has assumed expanded responsibilities and the title of Chief Operating and Financial Officer. In addition, the Company announced that Hollis Winkler joined the Company as Senior Vice President, Human Resources. With her hiring, Ms. Winkler joined the SeaSpine Senior Leadership Team. Mr. Bostjancic has served as SeaSpine's Chief Financial Officer since 2015. He has been an influentia

      5/3/22 4:04:00 PM ET
      $SPNE
      Medical Specialities
      Health Care
    • SeaSpine® Announces New Senior Leadership Team Appointments

      CARLSBAD, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the elevation of Dr. Frank Vizesi to Chief Scientific Officer and Shaeffer Bannigan to Vice President, Product Development, Spinal Implants. With his promotion, Mr. Bannigan joins the SeaSpine Senior Leadership Team. Dr. Vizesi joined SeaSpine in 2015 as Director, Research and Development, Orthobiologics. He quickly elevated the approach and defined the vision for delivering best-in-class orthobiologics procedural solutions. Under Dr. Vizesi's leadership, the team deepened

      3/7/22 4:05:00 PM ET
      $SPNE
      Medical Specialities
      Health Care
    • SeaSpine Appoints Seasoned Healthcare Executive to its Board of Directors

      CARLSBAD, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has appointed Angela Steinway to its Board of Directors, effective December 14, 2021. Ms. Steinway will serve as a member of the company's Audit Committee. With the appointment of Ms. Steinway, the SeaSpine Board of Directors now consists of nine directors, eight of whom are independent. Ms. Steinway brings over 15 years of experience in the medical device industry, having worked in various strategy, sales and finance functions throughout her career. Currently, she i

      12/14/21 4:05:00 PM ET
      $SPNE
      Medical Specialities
      Health Care

    $SPNE
    Financials

    Live finance-specific insights

    See more
    • SeaSpine to Report Third Quarter 2022 Financial Results on November 1, 2022

      CARLSBAD, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release third quarter financial results after the close of trading on Tuesday, November 1, 2022. Members of the Company's management team will host a corresponding conference call and webcast beginning at 1:30 pm PT / 4:30 pm ET. To listen to the live webcast and a replay, please visit the Investors section of the SeaSpine website at: https://www.seaspine.com/. About SeaSpine SeaSpine (www.seaspine.com) is a global medical technology company focused on the des

      10/24/22 7:00:00 AM ET
      $SPNE
      Medical Specialities
      Health Care
    • Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company

      Highly complementary spine and orthopedics portfoliosOne of the industry's broadest biologics and regenerative technology offeringsDifferentiated and synergistic enabling technologiesMeaningful cross-selling revenue synergies and cost savingsFinancial strength to pursue growth investments without need for immediate equity financing Expected to be adjusted EBITDA accretive to Orthofix by the second year following close including cost savings Companies to host joint conference call and webcast today at 8:00 a.m. ET LEWISVILLE, Texas and CARLSBAD, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) --  Orthofix (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, and SeaSpin

      10/11/22 6:00:00 AM ET
      $OFIX
      $SPNE
      Medical/Dental Instruments
      Health Care
      Medical Specialities
    • SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022 and Raises Full Year 2022 Revenue Guidance

      CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today second quarter financial results for the three-months ended June 30, 2022. Summary Second Quarter 2022 Financial Results and Recent Highlights Total revenue of $56.3 million, an increase of 19% year-over-yearU.S. revenue of $49.5 million, an increase of 16% year-over-year U.S. spinal implants and enabling technologies revenue of $25.0 million, an increase of 17% year-over-yearU.S. orthobiologics revenue of $24.5 million, an increase of 16% year-over-year International reve

      8/2/22 4:05:00 PM ET
      $SPNE
      Medical Specialities
      Health Care

    $SPNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Stephenson Kirtley C. returned 138,340 shares to the company, closing all direct ownership in the company

      4 - SeaSpine Holdings Corp (0001637761) (Issuer)

      1/9/23 7:21:07 PM ET
      $SPNE
      Medical Specialities
      Health Care
    • SEC Form 4: Steinway Angela returned 23,725 shares to the company, closing all direct ownership in the company

      4 - SeaSpine Holdings Corp (0001637761) (Issuer)

      1/9/23 7:20:51 PM ET
      $SPNE
      Medical Specialities
      Health Care
    • SEC Form 4: Maniar Shweta returned 23,993 shares to the company, closing all direct ownership in the company

      4 - SeaSpine Holdings Corp (0001637761) (Issuer)

      1/9/23 7:20:35 PM ET
      $SPNE
      Medical Specialities
      Health Care